Pharma Stocks Outlook for the week – 15 to 19.06.2015
(Seen
negative bias next week)
( www.rupeedesk.in )
Even
as a negative bias towards shares of pharmaceutical companies is seen
continuing next week due to correction, shares of mid-cap drug makers are
likely to perform better than their blue-chip peers.
During
this week a good correction was seen in the pharma stocks, which is expected to
continue going ahead also. Outlook is weak for both the medium term and the
short term. Despite the correction in the sector, lesser weakness was witnessed
in the mid-cap stocks compared to their blue-chip counterparts, and due to
this, the former would outperform the latter next week.
Stocks
of Hyderabad-based Aurobindo Pharma Ltd and Mumbai-based Glenmark
Pharmaceuticals Ltd were seen outperforming the sector during the next week. He
has a negative outlook of larger companies such as Cipla Ltd, Lupin Ltd and Sun
Pharmaceutical Industries Ltd.
